Colgate-Palmolive (NYSE:CL) Shares Sold by TIAA Trust National Association

TIAA Trust National Association decreased its stake in Colgate-Palmolive (NYSE:CLFree Report) by 2.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 58,861 shares of the company’s stock after selling 1,242 shares during the period. TIAA Trust National Association’s holdings in Colgate-Palmolive were worth $4,692,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Geode Capital Management LLC boosted its holdings in shares of Colgate-Palmolive by 0.6% in the 1st quarter. Geode Capital Management LLC now owns 17,457,294 shares of the company’s stock valued at $1,309,583,000 after buying an additional 112,177 shares in the last quarter. Morgan Stanley boosted its holdings in shares of Colgate-Palmolive by 3.2% in the 3rd quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock valued at $1,195,785,000 after buying an additional 514,559 shares in the last quarter. Moneta Group Investment Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 90,253.2% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,974,451 shares of the company’s stock valued at $1,258,627,000 after buying an additional 15,956,771 shares in the last quarter. Northern Trust Corp boosted its holdings in shares of Colgate-Palmolive by 0.5% in the 1st quarter. Northern Trust Corp now owns 10,470,409 shares of the company’s stock valued at $793,971,000 after buying an additional 50,040 shares in the last quarter. Finally, Norges Bank acquired a new stake in Colgate-Palmolive during the 4th quarter worth $644,715,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

CL has been the subject of a number of recent research reports. Wells Fargo & Company increased their price target on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Monday, January 29th. JPMorgan Chase & Co. increased their price target on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a research note on Thursday, January 18th. Morgan Stanley increased their price target on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research note on Monday, January 29th. Bank of America upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and set a $90.00 price target for the company in a research note on Friday, December 15th. Finally, StockNews.com cut shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $87.31.

View Our Latest Stock Analysis on CL

Insider Buying and Selling

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 29,772 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $84.06, for a total transaction of $2,502,634.32. Following the transaction, the chief executive officer now directly owns 301,343 shares of the company’s stock, valued at $25,330,892.58. The sale was disclosed in a filing with the SEC, which is available at this link. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 29,772 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $84.06, for a total transaction of $2,502,634.32. Following the transaction, the chief executive officer now directly owns 301,343 shares of the company’s stock, valued at $25,330,892.58. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director C Martin Harris sold 2,760 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the transaction, the director now directly owns 19,272 shares in the company, valued at $1,628,484. The disclosure for this sale can be found here. Over the last three months, insiders have sold 232,371 shares of company stock valued at $19,505,099. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $89.10 on Wednesday. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $90.37. The stock has a market capitalization of $73.24 billion, a P/E ratio of 32.05, a P/E/G ratio of 3.39 and a beta of 0.42. The firm’s 50-day moving average is $86.08 and its two-hundred day moving average is $79.45. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings results on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. During the same period last year, the company earned $0.77 EPS. The firm’s revenue for the quarter was up 6.9% compared to the same quarter last year. Equities analysts predict that Colgate-Palmolive will post 3.49 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a $0.50 dividend. The ex-dividend date is Friday, April 19th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a dividend yield of 2.24%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 69.06%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.